The global market for Real-Time PCR Assays was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Real-Time PCR Assays was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Real-Time PCR Assays was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Real-Time PCR Assays was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Real-Time PCR Assays include Roche, BLIRT, Qiagen, Merck, Ampliqon, Applied Biosystems, Bio-Rad, Takara Bio and Illumina, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Real-Time PCR Assays, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Real-Time PCR Assays by region & country, by Type, and by Application.
The Real-Time PCR Assays market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Real-Time PCR Assays.
麻豆原创 Segmentation
By Company
Roche
BLIRT
Qiagen
Merck
Ampliqon
Applied Biosystems
Bio-Rad
Takara Bio
Illumina
Thermo Fisher Scientific
Promega
New England Biolabs
Bioneer
Segment by Type:
Relative Quantification
Absolute Quantification
Segment by Application
PCR
RT-PCR
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Real-Time PCR Assays manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Real-Time PCR Assays in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Real-Time PCR Assays in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Real-Time PCR Assays Product Introduction
1.2 Global Real-Time PCR Assays 麻豆原创 Size Forecast
1.2.1 Global Real-Time PCR Assays Sales Value (2019-2030)
1.2.2 Global Real-Time PCR Assays Sales Volume (2019-2030)
1.2.3 Global Real-Time PCR Assays Sales Price (2019-2030)
1.3 Real-Time PCR Assays 麻豆原创 Trends & Drivers
1.3.1 Real-Time PCR Assays Industry Trends
1.3.2 Real-Time PCR Assays 麻豆原创 Drivers & Opportunity
1.3.3 Real-Time PCR Assays 麻豆原创 Challenges
1.3.4 Real-Time PCR Assays 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Real-Time PCR Assays Players Revenue Ranking (2023)
2.2 Global Real-Time PCR Assays Revenue by Company (2019-2024)
2.3 Global Real-Time PCR Assays Players Sales Volume Ranking (2023)
2.4 Global Real-Time PCR Assays Sales Volume by Company Players (2019-2024)
2.5 Global Real-Time PCR Assays Average Price by Company (2019-2024)
2.6 Key Manufacturers Real-Time PCR Assays Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Real-Time PCR Assays Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Real-Time PCR Assays
2.9 Real-Time PCR Assays 麻豆原创 Competitive Analysis
2.9.1 Real-Time PCR Assays 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Real-Time PCR Assays Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Real-Time PCR Assays as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Relative Quantification
3.1.2 Absolute Quantification
3.2 Global Real-Time PCR Assays Sales Value by Type
3.2.1 Global Real-Time PCR Assays Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Real-Time PCR Assays Sales Value, by Type (2019-2030)
3.2.3 Global Real-Time PCR Assays Sales Value, by Type (%) (2019-2030)
3.3 Global Real-Time PCR Assays Sales Volume by Type
3.3.1 Global Real-Time PCR Assays Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Real-Time PCR Assays Sales Volume, by Type (2019-2030)
3.3.3 Global Real-Time PCR Assays Sales Volume, by Type (%) (2019-2030)
3.4 Global Real-Time PCR Assays Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 PCR
4.1.2 RT-PCR
4.2 Global Real-Time PCR Assays Sales Value by Application
4.2.1 Global Real-Time PCR Assays Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Real-Time PCR Assays Sales Value, by Application (2019-2030)
4.2.3 Global Real-Time PCR Assays Sales Value, by Application (%) (2019-2030)
4.3 Global Real-Time PCR Assays Sales Volume by Application
4.3.1 Global Real-Time PCR Assays Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Real-Time PCR Assays Sales Volume, by Application (2019-2030)
4.3.3 Global Real-Time PCR Assays Sales Volume, by Application (%) (2019-2030)
4.4 Global Real-Time PCR Assays Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Real-Time PCR Assays Sales Value by Region
5.1.1 Global Real-Time PCR Assays Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Real-Time PCR Assays Sales Value by Region (2019-2024)
5.1.3 Global Real-Time PCR Assays Sales Value by Region (2025-2030)
5.1.4 Global Real-Time PCR Assays Sales Value by Region (%), (2019-2030)
5.2 Global Real-Time PCR Assays Sales Volume by Region
5.2.1 Global Real-Time PCR Assays Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Real-Time PCR Assays Sales Volume by Region (2019-2024)
5.2.3 Global Real-Time PCR Assays Sales Volume by Region (2025-2030)
5.2.4 Global Real-Time PCR Assays Sales Volume by Region (%), (2019-2030)
5.3 Global Real-Time PCR Assays Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Real-Time PCR Assays Sales Value, 2019-2030
5.4.2 North America Real-Time PCR Assays Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Real-Time PCR Assays Sales Value, 2019-2030
5.5.2 Europe Real-Time PCR Assays Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Real-Time PCR Assays Sales Value, 2019-2030
5.6.2 Asia Pacific Real-Time PCR Assays Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Real-Time PCR Assays Sales Value, 2019-2030
5.7.2 South America Real-Time PCR Assays Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Real-Time PCR Assays Sales Value, 2019-2030
5.8.2 Middle East & Africa Real-Time PCR Assays Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Real-Time PCR Assays Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Real-Time PCR Assays Sales Value
6.2.1 Key Countries/Regions Real-Time PCR Assays Sales Value, 2019-2030
6.2.2 Key Countries/Regions Real-Time PCR Assays Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Real-Time PCR Assays Sales Value, 2019-2030
6.3.2 United States Real-Time PCR Assays Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Real-Time PCR Assays Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Real-Time PCR Assays Sales Value, 2019-2030
6.4.2 Europe Real-Time PCR Assays Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Real-Time PCR Assays Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Real-Time PCR Assays Sales Value, 2019-2030
6.5.2 China Real-Time PCR Assays Sales Value by Type (%), 2023 VS 2030
6.5.3 China Real-Time PCR Assays Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Real-Time PCR Assays Sales Value, 2019-2030
6.6.2 Japan Real-Time PCR Assays Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Real-Time PCR Assays Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Real-Time PCR Assays Sales Value, 2019-2030
6.7.2 South Korea Real-Time PCR Assays Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Real-Time PCR Assays Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Real-Time PCR Assays Sales Value, 2019-2030
6.8.2 Southeast Asia Real-Time PCR Assays Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Real-Time PCR Assays Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Real-Time PCR Assays Sales Value, 2019-2030
6.9.2 India Real-Time PCR Assays Sales Value by Type (%), 2023 VS 2030
6.9.3 India Real-Time PCR Assays Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Company Information
7.1.2 Roche Introduction and Business Overview
7.1.3 Roche Real-Time PCR Assays Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Roche Real-Time PCR Assays Product Offerings
7.1.5 Roche Recent Development
7.2 BLIRT
7.2.1 BLIRT Company Information
7.2.2 BLIRT Introduction and Business Overview
7.2.3 BLIRT Real-Time PCR Assays Sales, Revenue and Gross Margin (2019-2024)
7.2.4 BLIRT Real-Time PCR Assays Product Offerings
7.2.5 BLIRT Recent Development
7.3 Qiagen
7.3.1 Qiagen Company Information
7.3.2 Qiagen Introduction and Business Overview
7.3.3 Qiagen Real-Time PCR Assays Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Qiagen Real-Time PCR Assays Product Offerings
7.3.5 Qiagen Recent Development
7.4 Merck
7.4.1 Merck Company Information
7.4.2 Merck Introduction and Business Overview
7.4.3 Merck Real-Time PCR Assays Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Merck Real-Time PCR Assays Product Offerings
7.4.5 Merck Recent Development
7.5 Ampliqon
7.5.1 Ampliqon Company Information
7.5.2 Ampliqon Introduction and Business Overview
7.5.3 Ampliqon Real-Time PCR Assays Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Ampliqon Real-Time PCR Assays Product Offerings
7.5.5 Ampliqon Recent Development
7.6 Applied Biosystems
7.6.1 Applied Biosystems Company Information
7.6.2 Applied Biosystems Introduction and Business Overview
7.6.3 Applied Biosystems Real-Time PCR Assays Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Applied Biosystems Real-Time PCR Assays Product Offerings
7.6.5 Applied Biosystems Recent Development
7.7 Bio-Rad
7.7.1 Bio-Rad Company Information
7.7.2 Bio-Rad Introduction and Business Overview
7.7.3 Bio-Rad Real-Time PCR Assays Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Bio-Rad Real-Time PCR Assays Product Offerings
7.7.5 Bio-Rad Recent Development
7.8 Takara Bio
7.8.1 Takara Bio Company Information
7.8.2 Takara Bio Introduction and Business Overview
7.8.3 Takara Bio Real-Time PCR Assays Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Takara Bio Real-Time PCR Assays Product Offerings
7.8.5 Takara Bio Recent Development
7.9 Illumina
7.9.1 Illumina Company Information
7.9.2 Illumina Introduction and Business Overview
7.9.3 Illumina Real-Time PCR Assays Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Illumina Real-Time PCR Assays Product Offerings
7.9.5 Illumina Recent Development
7.10 Thermo Fisher Scientific
7.10.1 Thermo Fisher Scientific Company Information
7.10.2 Thermo Fisher Scientific Introduction and Business Overview
7.10.3 Thermo Fisher Scientific Real-Time PCR Assays Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Thermo Fisher Scientific Real-Time PCR Assays Product Offerings
7.10.5 Thermo Fisher Scientific Recent Development
7.11 Promega
7.11.1 Promega Company Information
7.11.2 Promega Introduction and Business Overview
7.11.3 Promega Real-Time PCR Assays Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Promega Real-Time PCR Assays Product Offerings
7.11.5 Promega Recent Development
7.12 New England Biolabs
7.12.1 New England Biolabs Company Information
7.12.2 New England Biolabs Introduction and Business Overview
7.12.3 New England Biolabs Real-Time PCR Assays Sales, Revenue and Gross Margin (2019-2024)
7.12.4 New England Biolabs Real-Time PCR Assays Product Offerings
7.12.5 New England Biolabs Recent Development
7.13 Bioneer
7.13.1 Bioneer Company Information
7.13.2 Bioneer Introduction and Business Overview
7.13.3 Bioneer Real-Time PCR Assays Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Bioneer Real-Time PCR Assays Product Offerings
7.13.5 Bioneer Recent Development
8 Industry Chain Analysis
8.1 Real-Time PCR Assays Industrial Chain
8.2 Real-Time PCR Assays Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Real-Time PCR Assays Sales Model
8.5.2 Sales Channel
8.5.3 Real-Time PCR Assays Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Roche
BLIRT
Qiagen
Merck
Ampliqon
Applied Biosystems
Bio-Rad
Takara Bio
Illumina
Thermo Fisher Scientific
Promega
New England Biolabs
Bioneer
听
听
*If Applicable.